中草药

延胡索乙素治疗心血管疾病的研究进展

PDF下载

中草药 | 综述 2026,57(3): 1195-1208

收起

中草药 |综述 2026 , 57 (3) : 1195 -1208

延胡索乙素治疗心血管疾病的研究进展

全屏

刘祎¹, 李敬瑄¹, 董维冲¹, 袁叶¹, 杨秀岭¹

作者信息

通讯作者:

杨秀岭

作者简介:

刘祎: 刘祎（1991—），女，硕士研究生，主管药师，研究方向为临床药学。E-mail:yxyliuyi@163.com

Research progress on tetrahydropalmatine in treatment of cardiovascular diseases

LIU Yi, LI Jingxuan, DONG Weichong, YUAN Ye, YANG Xiuling

Affiliations

doi: 10.7501/j.issn.0253-2670.2026.03.034

文章导航

摘要

收起

心血管疾病是全球死亡和致残的首要原因，现有标准治疗虽能降低急性事件风险，但“残余风险”依然显著，亟需多靶点干预策略。延胡索乙素（tetrahydropalmatine，THP）作为延胡索生物碱中的主要活性成分，具有独特的四环骨架结构和多靶点药理特性，在心律失常、血小板过度聚集与血栓形成、高血压及内皮功能障碍、心室重塑等关键病理环节均发挥显著作用，其机制涉及多离子通道协同调控、一氧化氮合成与内皮依赖性舒张增强、交感神经活性抑制、纤维化及肥厚抑制等。此外，THP还可通过激活磷脂酰肌醇3-激酶/蛋白激酶B通路等保护性通路，抑制丝裂原活化蛋白激酶通路、核因子κB通路等致病性通路，从而发挥抗炎、抗凋亡、抗氧化及促血管新生等综合效应。然而，THP仍存在口服生物利用度有限、体内代谢途径复杂以及临床循证研究不足等关键障碍。因此，本综述系统梳理了THP在心血管疾病中的药理作用及分子机制，旨在揭示其多靶点、多通路的潜在价值，并为后续药动学优化、制剂改良及临床研究提供理论依据。

关键词

延胡索乙素 / 心血管疾病 / 抗炎 / 抗凋亡 / 抗氧化 / 心律失常 / 内皮功能障碍 / 心室重塑

Abstract

收起

Cardiovascular diseases are the leading cause of death and disability worldwide. Although existing standard therapies can reduce the risk of acute events, a significant “residual risk” remains, highlighting the urgent need for multi-target intervention strategies. Tetrahydropalmatine (THP), the principal active alkaloid in Corydalis yanhusuo, features a unique tetracyclic scaffold and exhibits multitarget pharmacological characteristics. It plays significant roles in key pathological processes, including arrhythmia, platelet hyperaggregation and thrombosis, hypertension and endothelial dysfunction, and ventricular remodeling. Its mechanisms involve the coordinated regulation of multiple ion channels, enhancement of nitric oxide synthesis and endothelium-dependent relaxation, suppression of sympathetic nerve activity, and inhibition of fibrosis and hypertrophy. Furthermore, THP can activate protective signaling pathways such as the phosphatidylinositol 3-kinase/protein kinase B pathway, while inhibiting pathogenic pathways including the mitogen-activated protein kinase and nuclear factor-κB pathways, thereby exerting comprehensive effects such as anti-inflammatory, anti-apoptotic, antioxidant, and pro-angiogenic actions. However, THP still faces critical limitations, including low oral bioavailability, complex metabolic pathways, and insufficient clinical evidence. Therefore, this review systematically summarizes the pharmacological effects and molecular mechanisms of THP in cardiovascular diseases, aiming to elucidate its potential value as a multi-target and multi-pathway therapeutic agent, and to provide a theoretical foundation for further pharmacokinetic optimization, formulation improvement, and clinical investigation.

Key words

tetrahydropalmatine / cardiovascular diseases / anti-inflammatory / anti-apoptotic / antioxidant / arrhythmia / endothelial dysfunction / ventricular remodeling

引用本文

刘祎, 李敬瑄, 董维冲, 袁叶, 杨秀岭. 延胡索乙素治疗心血管疾病的研究进展. 中草药, 2026 , 57 (3) : 1195 -1208 . DOI: 10.7501/j.issn.0253-2670.2026.03.034

LIU Yi, LI Jingxuan, DONG Weichong, YUAN Ye, YANG Xiuling. Research progress on tetrahydropalmatine in treatment of cardiovascular diseases[J]. Chinese Traditional and Herbal Drugs, 2026 , 57 (3) : 1195 -1208 . DOI: 10.7501/j.issn.0253-2670.2026.03.034

基金

收起

河北省医学科学研究课题(20230608)

参考文献

收起

文献

收起

参考文献引证文献

排序方式：

Goldsborough E 3rd, Osuji N, Blaha M J. Assessment of cardiovascular disease risk: A 2022 update [J]. Endocrinol Metab Clin North Am, 2022, 51(3): 483-509.
Soppert J, Lehrke M, Marx N, et al. Lipoproteins and lipids in cardiovascular disease: From mechanistic insights to therapeutic targeting [J]. Adv Drug Deliv Rev, 2020, 159: 4-33.
Di Cesare M, Perel P, Taylor S, et al. The heart of the world [J]. Glob Heart, 2024, 19: 11.
Lindstrom M, DeCleene N, Dorsey H, et al. Global burden of cardiovascular diseases and risks collaboration, 1990-2021 [J]. J Am Coll Cardiol, 2022, 80(25): 2372-2425.
Mach F, Baigent C, Catapano A L, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk [J]. Eur Heart J, 2020, 41(1): 111-188.
Visseren F L J，Mach F，Smulders Y M，et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice [J]. Eur Heart J，2021，42(34)：3227–3337.
Giubilato S, Lucà F, Abrignani M G, et al. Management of residual risk in chronic coronary syndromes. clinical pathways for a quality-based secondary prevention [J]. J Clin Med, 2023, 12(18): 5989.
Ridker P M, Everett B M, Thuren T, et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease [J]. N Engl J Med, 2017, 377(12): 1119-1131.
Nidorf S M, Fiolet A T L, Mosterd A, et al. Colchicine in patients with chronic coronary disease [J]. N Engl J Med, 2020, 383(19): 1838-1847.
雷斅. 雷公炮炙论 [M]. 南京: 江苏科学技术出版社, 1985: 89.
高风, 郭丽君, 王亦菲, 等. 延胡索治疗心血管疾病的研究进展 [J]. 中西医结合心脑血管病杂志, 2023, 21(12): 2198-2201.
杨晶莹, 田硕, 苗明三. 延胡索化学成分和药理作用研究进展及质量标志物的预测分析 [J]. 中华中医药学刊, 2025, 43(12): 119-125.
孙梦雪, 李玉婷. 延胡索乙素的药理作用研究进展 [J]. 山东化工, 2024, 53(13): 130-133.
Du Q Y, Meng X L, Wang S H. A comprehensive review on the chemical properties, plant sources, pharmacological activities, pharmacokinetic and toxicological characteristics of tetrahydropalmatine [J]. Front Pharmacol, 2022, 13: 890078.
Hong Z Y, Le J, Lin M, et al. Comparative studies on pharmacokinetic fates of tetrahydropalmatine enantiomers in different chemical environments in rats [J]. Chirality, 2008, 20(2): 119-124.
Jiang Y R, Xu H, et al. Molecular docking of the acetylcholinesterase inhibitor corydaline and virtual screening of open ring derivatives [J]. Acta Phys Chim Sin, 2009, 25(7): 1379-1384.
Yang X R, Miao X L, Dai L X, et al. Isolation, biological activity, and synthesis of isoquinoline alkaloids [J]. Nat Prod Rep, 2024, 41(11): 1652-1722.
Dorogan M, Namballa H K, Harding W W. Natural product-inspired dopamine receptor ligands [J]. J Med Chem, 2024, 67(15): 12463-12484.
Qu Z, Zhang J Z, Huo L Q, et al. Antihypertensive and vasorelaxant effects of Rhizoma corydalis and its active component tetrahydropalmatine via NO/cGMP pathway and calcium channel blockade in isolated rat thoracic aorta [J]. RSC Adv, 2015, 5(114): 94130-94143.
Li Y R, Zhang T, Huai J X, et al. Pharmacokinetic study of three different formulations of l-tetrahydropalmatine in brain tissues of rats [J]. Biomed Chromatogr, 2021, 35(5): e5066.
Wang S, Che T, Levit A, et al. Structure of the D2 dopamine receptor bound to the atypical antipsychotic drug risperidone [J]. Nature, 2018, 555(7695): 269-273.
吴佩盛, 黄善定, 叶亚菊, 等. 大鼠肠道对左旋延胡索乙素及其消旋体的吸收差异研究 [J]. 药学学报, 2007, 42(5): 534-537.
孙飞涵, 李聃宁, 杨华, 等. LncRNA-CCRR通过调控UBA6影响钠通道泛素化进而调控心梗后心律失常 [J]. 中国药理学通报, 2024, 40(8): 1437-1446.
Lee D P H, Cao Y, Zhang L L. Genetic landscape of hypertrophic cardiomyopathy in Hong Kong Chinese population [J]. Front Genet, 2025, 16: 1583838.
Yarnell E. Herbs for atrial fibrillation [J]. Altern Complementary Ther, 2017, 23(3): 102-111.
程龙献, 毛焕元, 戴水平, 等. 颅痛定对单个豚鼠心室肌细胞膜钙通道电流的影响 [J]. 临床心血管病杂志, 1995, 11(3): 170-172.
曾秋棠, 张桂清, 曹林生, 等. 四氢巴马汀抗触发性室性心律失常作用机制的研究 [J]. 中华内科杂志, 2000, 39(10): 667-669.
孟红旭, 姚明江, 任钧国, 等. 延胡索叔胺碱和季胺碱对豚鼠心室肌细胞动作电位和HERG通道电流的影响 [J]. 世界中医药, 2018, 13(1): 1-4.
Li K, Pi M S, Li X T. The inhibitory effects of levo-tetrahydropalmatine on rat Kv1.5 channels expressed in HEK293 cells [J]. Eur J Pharmacol, 2017, 809: 105-110.
Andersen M N, Skibsbye L, Tang C Y, et al. PKC and AMPK regulation of Kv1.5 potassium channels [J]. Channels, 2015, 9(3): 121-128.
张桂清, 曾秋棠, 曹林生, 等. 四氢巴马汀对氯化铯诱发家兔在体心脏早后除极和触发性室性心律失常作用的研究 [J]. 中华心律失常学杂志, 2000, 4(3): 208.
Wang C L, Skeie J M, Allamargot C, et al. Rat model of type 2 diabetes mellitus recapitulates human disease in the anterior segment of the eye [J]. Am J Pathol, 2024, 194(6): 1090-1105.
Theofilis P, Sagris M, Oikonomou E, et al. Factors associated with platelet activation-recent pharmaceutical approaches [J]. Int J Mol Sci, 2022, 23(6): 89.
Tian Y C, Zong Y, Pang Y D, et al. Platelets and diseases: Signal transduction and advances in targeted therapy [J]. Signal Transduct Target Ther, 2025, 10(1): 159.
邢建峰, 王美纳. dl―四氢巴汀对实验性脑血栓形成及体外血小板聚集的抑制作用 [J]. 中国药理学通报, 1997, 13(3): 258-260.
Zhang Q, Chen C, Wang F Q, et al. Simultaneous screening and analysis of antiplatelet aggregation active alkaloids from Rhizoma Corydalis [J]. Pharm Biol, 2016, 54(12): 3113-3120.
杨娟. 延胡索乙素抗血栓作用及机制研究 [D]. 郑州: 郑州大学, 2013.
庞国凤, 郝二伟, 周凯, 等. 调节血栓中组织因子表达的中药有效成分研究进展 [J]. 中草药, 2016, 47(6): 1043-1048.
Chen S, Tian C B, Bai L Y, et al. Thrombosis inhibited by Corydalis decumbens through regulating PI3K-Akt pathway [J]. J Ethnopharmacol, 2024, 329: 118177.
沈路凡, 王鸿, 吕红英, 等. 硫化氢在H型高血压中的研究进展 [J]. 中国药理学通报, 2024, 40(9): 1601-1607.
Gao S, Long C L, Wang R H, et al. K(ATP) activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function [J]. Cardiovasc Res, 2009, 83(3): 444-456.
Zhou Z Y, Zhao W R, Shi W T, et al. Endothelial-dependent and independent vascular relaxation effect of tetrahydropalmatine on rat aorta [J]. Front Pharmacol, 2019, 10: 336.
姚兵, 卞春甫, 秦伟. 左旋四氢巴马汀的降压作用 [J]. 徐州医学院学报, 1991, 11(1): 16-19.
Feng J H, Chen K, Shen S Y, et al. The composition, pharmacological effects, related mechanisms and drug delivery of alkaloids from Corydalis yanhusuo [J]. Biomed Pharmacother, 2023, 167: 115511.
Liu Y Y, Wang T X, Zhou J C, et al. Dopamine D(1) and D(2) receptors mediate analgesic and hypnotic effects of l-tetrahydropalmatine in a mouse neuropathic pain model [J]. Psychopharmacology, 2019, 236(11): 3169-3182.
Chu L H, Hsu F L, Chueh F Y, et al. Antihypertensive activity of dl-tetrahydropalmatine, an active alkaloid isolated from the tubers of Corydalis racemosa [J]. J Chin Chem Soc, 1996, 43(6): 489-492.
Chueh F Y, Hsieh M T, Chen C F, et al. Hypotensive and bradycardic effects of dl-tetrahydropalmatine mediated by decrease in hypothalamic serotonin release in the rat [J]. Jpn J Pharmacol, 1995, 69(2): 177-180.
Luo S Y, Xia W H, Chen C, et al. Endothelial progenitor cells and hypertension: Current concepts and future implications [J]. Clin Sci, 2016, 130(22): 2029-2042.
刘景芳, 屠洪, 方毅, 等. 急性下壁梗死发生房室传导阻滞的时间与预后关系 [J]. 中华急诊医学杂志, 2003, 12(7): 477-479.
曲卓. 养血清脑颗粒心脑血管保护作用及药效物质基础研究 [D]. 天津: 天津大学, 2017.
González A, López B, Ravassa S, et al. Myocardial interstitial fibrosis in hypertensive heart disease: From mechanisms to clinical management [J]. Hypertension, 2024, 81(2): 218-228.
Rosa S A. Prognosis after myocardial infarction - A deep look into myocardial tissue [J]. Arq Bras Cardiol, 2022, 119(6): 958-959.
Bers D M. Cardiac excitation-contraction coupling [J]. Nature, 2002, 415(6868): 198-205.
Richards D A, Aronovitz M J, Calamaras T D, et al. Distinct phenotypes induced by three degrees of transverse aortic constriction in mice [J]. Sci Rep, 2019, 9(1): 5844.
Muthuramu I, Lox M, Jacobs F, et al. Permanent ligation of the left anterior descending coronary artery in mice: A model of post-myocardial infarction remodelling and heart failure [J]. J Vis Exp, 2014(94): e52206.
Wen C P, Wu L M, Ling H Y, et al. Salutary effects of Corydalis yanhusuo extract on cardiac hypertrophy due to pressure overload in rats [J]. J Pharm Pharmacol, 2007, 59(8): 1159-1165.
承云, 戚本玲, 管思明, 等. L-四氢巴马汀对压力超负荷大鼠心肌肥厚细胞外基质增生的影响 [J]. 中国药理学通报, 2001, 17(3): 261-263.
闵清, 吴基良, 罗德生, 等. 7-氯苄基四氢巴马汀对大鼠心肌肥厚及左心室肌原纤维Ca²⁺-Mg²⁺-ATP酶活力的影响 [J]. 咸宁医学院学报, 2001(1): 26-28.
Wu L M, Ling H Y, Li L D, et al. Beneficial effects of the extract from Corydalis yanhusuo in rats with heart failure following myocardial infarction [J]. J Pharm Pharmacol, 2007, 59(5): 695-701.
Shiojima I, Walsh K. Role of Akt signaling in vascular homeostasis and angiogenesis [J]. Circ Res, 2002, 90(12): 1243-1250.
Yoshitomi H, Xu Q, Gao M, et al. Phosphorylated endothelial NOS Ser1177 via the PI3K/Akt pathway is depressed in the brain of stroke-prone spontaneously hypertensive rat [J]. J Stroke Cerebrovasc Dis, 2011, 20(5): 406-412.
Han Y, Zhang W, Tang Y, et al. L-tetrahydropalmatine, an active component of Corydalis yanhusuo W.T. Wang, protects against myocardial ischaemia-reperfusion injury in rats [J]. PLoS One, 2012, 7(6): e38627.
Cui H R, Yang X X, Wang Z D, et al. Tetrahydropalmatine triggers angiogenesis via regulation of arginine biosynthesis [J]. Pharmacol Res, 2021, 163: 105242.
Chen X K, Fu K J, Lai Y Y, et al. Tetrahydropalmatine: Orchestrating survival-regulating autophagy and apoptosis via the PI3K/AKT/mTOR pathway in perforator flaps [J]. Biomed Pharmacother, 2023, 169: 115887.
Canovas B, Nebreda A R. Diversity and versatility of p38 kinase signalling in health and disease [J]. Nat Rev Mol Cell Biol, 2021, 22(5): 346-366.
郭俊玲, 吴曼, 李颖, 等. 基于MAPK/ERK信号通路探究延胡索乙素对心肌梗死后心力衰竭大鼠的心肌保护作用 [J]. 中国药师, 2022, 25(5): 765-771.
Moustafa A, Hashemi S, Brar G, et al. The MEF2A transcription factor interactome in cardiomyocytes [J]. Cell Death Dis, 2023, 14(4): 240.
Wu D, Wang P, Zhao C H, et al. Levo-tetrahydropalmatine ameliorates neuropathic pain by inhibiting the activation of the Clec7a-MAPK/NF-κB-NLRP3 inflammasome axis [J]. Phytomedicine, 2023, 121: 155075.
Martin-Isla C, Campello V M, Izquierdo C, et al. Image-based cardiac diagnosis with machine learning: A review [J]. Front Cardiovasc Med, 2020, 7: 1.
Guo Q, Jin Y Z, Chen X Y, et al. NF-κB in biology and targeted therapy: New insights and translational implications [J]. Signal Transduct Target Ther, 2024, 9(1): 53.
Yang B R, Yu N, Deng Y H, et al. L-tetrahydropalamatine inhibits tumor necrosis factor-α-induced monocyte-endothelial cell adhesion through downregulation of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 involving suppression of nuclear factor-κ B signaling pathway [J]. Chin J Integr Med, 2015, 21(5): 361-368.
Ding K, Chen L J, He J Q, et al. Tetrahydropalmatine alleviates hyperlipidemia by regulating lipid peroxidation, endoplasmic reticulum stress, and inflammasome activation by inhibiting the TLR4-NF-κB pathway [J]. Evid Based Complement Alternat Med, 2021, 2021: 6614985.
Wang H, Ding K, He J Q, et al. Tetrahydropalmatine promotes macrophage autophagy by inhibiting the AMPK/mTOR pathway to attenuate atherosclerosis [J]. Histol Histopathol, 2025, 40(5): 697-710.
高风. 延胡索醇提物及延胡索乙素调节肠道菌群和胆汁酸代谢抗动脉粥样硬化作用和机制 [D]. 北京: 中国中医科学院, 2024.
Drăgoi C M, Diaconu C C, Nicolae A C, et al. Redox homeostasis and molecular biomarkers in precision therapy for cardiovascular diseases [J]. Antioxidants, 2024, 13(10): 1163.
Han B J, Cao G Y, Jia L Y, et al. Cardioprotective effects of tetrahydropalmatine on acute myocardial infarction in rats [J]. Am J Chin Med, 2022, 50(7): 1887-1904.
Ding K, Bao Q Y, He J Q, et al. Tetrahydropalmatine improves mitochondrial function in vascular smooth muscle cells of atherosclerosis in vitro by inhibiting Ras homolog gene family A/Rho-associated protein kinase-1 signaling pathway [J]. Open Med, 2025, 20(1): 20241059.
Bortolotto V, Bondi H, Cuccurazzu B, et al. Salmeterol, a β2 adrenergic agonist, promotes adult hippocampal neurogenesis in a region-specific manner [J]. Front Pharmacol, 2019, 10: 1000.
Bellezza I, Giambanco I, Minelli A, et al. Nrf2-Keap1 signaling in oxidative and reductive stress [J]. Biochim Biophys Acta Mol Cell Res, 2018, 1865(5): 721-733.
陈文明, 蹇明辉. 延胡索乙素改善PDGF-BB诱导的VSMCs氧化应激损伤的机制 [J]. 中国药房, 2024, 35(15): 1855-1861.
Song Y Q, Chen C, Li W. Ginsenoside Rb₁ in cardiovascular and cerebrovascular diseases: A review of therapeutic potentials and molecular mechanisms [J]. Chin Herb Med,2024, 16(4): 489-504.
Ling H Y, Wu L M, Li L D. Corydalis yanhusuo rhizoma extract reduces infarct size and improves heart function during myocardial ischemia/reperfusion by inhibiting apoptosis in rats [J]. Phytother Res, 2006, 20(6): 448-453.
蹇明辉, 陈文明, 张怡. 延胡索乙素对高糖诱导H9c2细胞凋亡和氧化应激的抑制作用 [J]. 遵义医科大学学报, 2022, 45(3): 317-321.
Obsilova V, Honzejkova K, Obsil T. Structural insights support targeting ASK1 kinase for therapeutic interventions [J]. Int J Mol Sci, 2021, 22(24): 13395.
Hong Y H, Boiti A, Vallone D, et al. Reactive oxygen species signaling and oxidative stress: Transcriptional regulation and evolution [J]. Antioxidants, 2024, 13(3): 312.
Wang Z Y, Liu W. Hemin as a protective agent in an in vitro model of hypoxia/reoxygenation-induced injury [J]. SAGE Open Med, 2025, 13: 20503121251329163.
Jung J W, Kwon Y S, Jeong J S, et al. Pharmacokinetics and brain distribution of tetrahydropalmatine and tetrahydroberberine after oral administration of DA-9701, a new botanical gastroprokinetic agent, in rats [J]. Biol Pharm Bull, 2015, 38(2): 285-291.
Sun S Y, Chen Z J, Li L P, et al. The two enantiomers of tetrahydropalmatine are inhibitors of P-gp, but not inhibitors of MRP1 or BCRP [J]. Xenobiotica, 2012, 42(12): 1197-1205.
Chueh F Y, Hsieh M T, Chen C F, et al. DL-tetrahydropalmatine-produced hypotension and bradycardia in rats through the inhibition of central nervous dopaminergic mechanisms [J]. Pharmacology, 1995, 51(4): 237-244.
Li C W, Zhang S, Gao H Q, et al. Determination of L-tetrahydropalmatine in human plasma by HPLC and pharmacokinetics of its disintegrating tablets in healthy Chinese [J]. Eur J Drug Metab Pharmacokinet, 2011, 36(4): 257-262.
Zhang G Z, Li X J, Huang C Y, et al. Preparation of the levo-tetrahydropalmatine liposome gel and its transdermal study [J]. Int J Nanomedicine, 2023, 18: 4617-4632.
Hassan H E, Kelly D, Honick M, et al. Pharmacokinetics and safety assessment of l-tetrahydropalmatine in cocaine users: A randomized, double-blind, placebo-controlled study [J]. J Clin Pharmacol, 2017, 57(2): 151-160.
Wang X, Zhao R, Zhang H G, et al. Levo-tetrahydropalmatine attenuates progression of abdominal aortic aneurysm in an elastase perfusion rat model via suppression of matrix metalloproteinase and monocyte chemotactic protein-1 [J]. Med Sci Monit, 2018, 24: 652-660.
Wu H Q, Xiong X T, Huang X L, et al. Simultaneous determination of 17 toxic alkaloids in human fluids by liquid chromatography coupled with electrospray ionization tandem mass spectrometry [J]. J Liq Chromatogr Relat Technol, 2013, 36(9): 1149-1162.
Zeng Y, Quek Y L, Kee C L, et al. Analysis of 32 toxic natural substances in herbal products by liquid chromatography quadrupole linear ion trap mass spectrometry [J]. J Pharm Biomed Anal, 2015, 115: 169-173.
徐婷, 曹惠明, 金昔陆. 延胡索乙素临床应用的研究进展 [J]. 上海中医药大学学报, 2000, 14(4): 60-63.
汪大金, 毛焕元, 雷明, 等. 新的植物性钙拮抗剂颅通定治疗心房颤动的临床研究 [J]. 中国中西医结合杂志, 1993, 13(8): 455-457.
任付先, 金爱萍, 牛小麟. 植物源性钙拮抗剂延胡索乙素的药理作用及临床应用 [J]. 世界最新医学信息文摘, 2003(3): 672-674.
陈礼平, 王德土, 陈文莉. 可达灵片治疗冠心病心绞痛及急性心肌梗塞疗效观察 [J]. 现代应用药学, 1996, 13(4): 56-57.
叶士勇, 胡武明, 曾春来, 等. 可达灵片辅助治疗冠心病不稳定型心绞痛的疗效及对血小板聚集、炎症因子的影响 [J]. 心脑血管病防治, 2019, 19(2): 151-152.
林锋. 可达灵片治疗冠心病心绞痛患者的临床效果 [J]. 医疗装备, 2018, 31(1): 155-156.

2026年第57卷第3期

PDF下载

引用本文

BibTeX

文章信息

doi: 10.7501/j.issn.0253-2670.2026.03.034

接收时间：2025-09-05
首发时间：2026-09-08

补充材料

相关文章

文章信息

作者

出版历史

收稿日期：2025-09-05

基金

作者信息

参考文献

分享链接

https://castjournals.cast.org.cn/joweb/zcy/CN/10.7501/j.issn.0253-2670.2026.03.034

分享至

全文二维码

扫描看全文

引用本文

BibTeX

本文的引用情况

2种不同金属材料的力学参数

科 Family	属数 Number of genus	种数 Number of species	占总种数比例 Percentage of total species (%)	属 Genus	种数 Number of species	占总种数比例 Percentage of total species (%)
鹅膏菌科Amanitaceae	2	11	5.26	鹅膏菌属 Amanita	10	4.78
小菇科 Mycenaceae	2	12	5.74	丝盖伞属 Inocybe	5	2.39
多孔菌科 Polyporaceae	8	14	6.70	蜡蘑属 Laccaria	5	2.39
红菇科 Russulaceae	3	23	11.00	小皮伞属 Marasmius	6	2.87
				小菇属 Mycena	11	5.26
				光柄菇属 Pluteus	5	2.39
				红菇属 Russula	17	8.13
				栓菌属 Trametes	5	2.39

关闭全屏

BibTeX
EndNote
RefWorks
TxT